MeSH tree: B01.043.075.380.611.561
A novel class of antibodies that binds to a previously untargeted portion of the malaria parasite could lead to new prevention methods, according to a study by researchers at the National Institutes of Health (NIH) published ...
Jan 3, 2025
0
51
Malaria, caused by a parasite transmitted to humans through an infected mosquito's bite, is a leading cause of illness and death worldwide.
Dec 18, 2024
0
19
The results of a clinical trial into a new malaria vaccine candidate (RH5.1/Matrix-MTM) show it is well-tolerated and offers effective protection against the blood-stage of the disease—the first inoculation to do so.
Dec 11, 2024
0
31
Scientists have unveiled a new tool for studying the highly variable traits that allow malaria parasites to stick to red blood cells and evade the immune system.
Nov 26, 2024
0
12
Mutations in malarial parasites linked to artemisinin-resistance in Southeast Asia have now been found in African children hospitalized for complicated malaria, according to a new study presented at the Annual Meeting of ...
Nov 14, 2024
0
25
An international team of researchers have developed a promising new drug that could help combat the spread of treatment-resistant malaria.
Nov 4, 2024
0
27
Almost half of the world's population is at risk of malaria infection, with children and pregnant women at the highest risk of getting sick and dying from the disease. Current methods to detect this potentially deadly infection ...
Oct 29, 2024
0
32
In 2022, nearly 619,000 global deaths due to malaria were caused by Plasmodium falciparum, the most virulent, prevalent, and deadly human malaria parasite. For decades, the parasite's resistance to all antimalarial drugs ...
Sep 26, 2024
0
45
Near the heavily fortified border that divides North and South Korea, a monitoring device is working 24-7—not tracking missiles or troop movements, but catching malaria-carrying mosquitoes that may cross the border.
Aug 27, 2024
0
35
Two trials of an experimental malaria vaccine in healthy Malian adults found that all three tested regimens were safe. The findings are published in The Lancet Infectious Diseases journal.
Aug 15, 2024
0
40
